CytoMed Therapeutics Stock Forecast - Period Momentum Indicator
| GDTC Stock | 2.29 0.67 22.64% |
CytoMed Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast CytoMed Therapeutics stock prices and determine the direction of CytoMed Therapeutics Limited's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of CytoMed Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
CytoMed |
| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (0.67) | (0.67) |
| Check CytoMed Therapeutics Volatility | Backtest CytoMed Therapeutics | Information Ratio |
CytoMed Therapeutics Trading Date Momentum
| On January 08 2025 CytoMed Therapeutics Limited was traded for 2.29 at the closing time. The top price for the day was 2.85 and the lowest listed price was 2.29 . The trading volume for the day was 200.7 K. The trading history from January 8, 2025 did not affect price variability. The overall trading delta against the current closing price is 24.45% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare CytoMed Therapeutics to competition |
Other Forecasting Options for CytoMed Therapeutics
For every potential investor in CytoMed, whether a beginner or expert, CytoMed Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CytoMed Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CytoMed. Basic forecasting techniques help filter out the noise by identifying CytoMed Therapeutics' price trends.View CytoMed Therapeutics Related Equities
| Risk & Return | Correlation |
CytoMed Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of CytoMed Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of CytoMed Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
CytoMed Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how CytoMed Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CytoMed Therapeutics shares will generate the highest return on investment. By undertsting and applying CytoMed Therapeutics stock market strength indicators, traders can identify CytoMed Therapeutics Limited entry and exit signals to maximize returns.
| Accumulation Distribution | 39439.13 | |||
| Daily Balance Of Power | (1.20) | |||
| Rate Of Daily Change | 0.77 | |||
| Day Median Price | 2.57 | |||
| Day Typical Price | 2.48 | |||
| Price Action Indicator | (0.61) | |||
| Period Momentum Indicator | (0.67) |
CytoMed Therapeutics Risk Indicators
The analysis of CytoMed Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in CytoMed Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cytomed stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.35 | |||
| Semi Deviation | 5.36 | |||
| Standard Deviation | 7.59 | |||
| Variance | 57.58 | |||
| Downside Variance | 36.16 | |||
| Semi Variance | 28.71 | |||
| Expected Short fall | (6.36) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Historical Fundamental Analysis of CytoMed Therapeutics to cross-verify your projections. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CytoMed Therapeutics. If investors know CytoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CytoMed Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.22) | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets | Return On Equity |
The market value of CytoMed Therapeutics is measured differently than its book value, which is the value of CytoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CytoMed Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CytoMed Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CytoMed Therapeutics' market value can be influenced by many factors that don't directly affect CytoMed Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CytoMed Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CytoMed Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CytoMed Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.